{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:18:34Z","timestamp":1789517914197,"version":"build-2803163510"},"reference-count":47,"publisher":"SAGE Publications","issue":"1_suppl","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100001009","name":"Bristol-Myers Squibb Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Public Health Rep"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1177\/0033354920904608","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T10:50:45Z","timestamp":1596192645000},"page":"44S-49S","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["Enforcement of Legal Remedies to Secure Hepatitis C Virus Treatment With Direct-Acting Antiviral Therapies in Correctional Facilities and Medicaid Programs"],"prefix":"10.1177","volume":"135","author":[{"given":"Robert","family":"Greenwald","sequence":"first","affiliation":[{"name":"Center for Health Law and Policy Innovation, Harvard Law School, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1028-7984","authenticated-orcid":false,"given":"Phillip","family":"Waters","sequence":"additional","affiliation":[{"name":"Center for Health Law and Policy Innovation, Harvard Law School, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cayer","sequence":"additional","affiliation":[{"name":"Center for Health Law and Policy Innovation, Harvard Law School, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"bibr1-0033354920904608","unstructured":"New hepatitis C infections nearly tripled over five years [news release]. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; May 11, 2017. https:\/\/www.cdc.gov\/media\/releases\/2017\/p-hepatitis-c-infections-tripled.html. Accessed March 31, 2019."},{"key":"bibr2-0033354920904608","unstructured":"Erickson SC, Qiu W, Maas-Patel CR, Wang SM, Patel BV. Recent trends in the treatment of chronic hepatitis C. Pharmacy Times. April 16, 2014. https:\/\/www.pharmacytimes.com\/publications\/ajpb\/2014\/ajpb_marapr2014\/recent-trends-in-the-treatment-of-chronic-hepatitis-c. Accessed March 1, 2019."},{"key":"bibr3-0033354920904608","unstructured":"American Association for the Study of Liver Diseases, Infectious Diseases Society of America. Key populations: identification and management of HCV in people who inject drugs. Updated May 24, 2018. https:\/\/www.hcvguidelines.org\/unique-populations\/pwid. Accessed March 31, 2019."},{"key":"bibr4-0033354920904608","unstructured":"Bruen B, Brantley E, Thompson V, Steinmetz E, Helmchen L. High-Cost HCV Drugs in Medicaid: Final Report. Washington, DC: George Washington University, Milken Institute School of Public Health; January 2017. https:\/\/www.macpac.gov\/wp-content\/uploads\/2017\/03\/High-Cost-HCV-Drugs-in-Medicaid-Final-Report.pdf. Accessed March 31, 2019."},{"key":"bibr5-0033354920904608","unstructured":"Center for Health Law and Policy Innovation, Harvard Law School. Hepatitis C: the state of Medicaid access\u20142017 national summary report. October 23, 2017. https:\/\/stateofhepc.org\/wp-content\/uploads\/2017\/10\/State-of-HepC_2017_FINAL.pdf. Accessed March 31, 2019."},{"key":"bibr6-0033354920904608","doi-asserted-by":"publisher","DOI":"10.1097\/PHH.0000000000000829"},{"key":"bibr7-0033354920904608","doi-asserted-by":"crossref","unstructured":"Hoffer v Jones\n                      , 290 F Supp 3d 1292 (2017).","DOI":"10.4324\/9781315168302-28"},{"key":"bibr8-0033354920904608","unstructured":"Stafford v Carter\n                      , 1:17-CV-00289, Dist Ct SD Indiana (2018)."},{"key":"bibr9-0033354920904608","unstructured":"Chimenti v Wetzel\n                      , 15-3333, East Dist Pa (2018)."},{"key":"bibr10-0033354920904608","unstructured":"Medicaid Act, 42 USC \u00a71396 et seq (1965)."},{"key":"bibr11-0033354920904608","unstructured":"Center for Health Law and Policy Innovation, Harvard Law School. Hepatitis C: the state of Medicaid access: 1\/31\/19 update. https:\/\/www.chlpi.org\/wp-content\/uploads\/2013\/12\/HCV_State-of-Medicaid-Access_January-2019-update-1.pdf. Accessed March 31, 2019."},{"key":"bibr12-0033354920904608","unstructured":"Americans with Disabilities Act, Pub L No 101-336, 42 USC \u00a7\u00a7 12101-12213 (1990)."},{"key":"bibr13-0033354920904608","unstructured":"Estelle v Gamble\n                      , 429 US 97 (1976)."},{"key":"bibr14-0033354920904608","unstructured":"Medicaid Act, 42 USC \u00a71396a(a)(10)(A) (2019)."},{"key":"bibr15-0033354920904608","unstructured":"Abu-Jamal v Wetzel\n                      , 3:16-CV-2000, Md Penn (2017)."},{"key":"bibr16-0033354920904608","unstructured":"Phelps v Wexford Health Sources, Inc\n                      , ELH-16-2675, D Md (2017)."},{"key":"bibr17-0033354920904608","unstructured":"Pevia v Wexford Health Sources, Inc\n                      , ELH-16-1950, D Md (2018)."},{"key":"bibr18-0033354920904608","unstructured":"Allah v Thomas\n                      , 16-3103, 3d Cir (2017)."},{"key":"bibr19-0033354920904608","unstructured":"Cunningham v Sessions\n                      , 9:16-cv-1292-RMG, DSC (2017)."},{"key":"bibr20-0033354920904608","unstructured":"BE v Teeter\n                      , C16-227-JCC, WD Wash (2016)."},{"key":"bibr21-0033354920904608","unstructured":"Ryan v Birch\n                      , 17-cv-00904-KLM, D Colo (2017)."},{"key":"bibr22-0033354920904608","unstructured":"MR v Lyon\n                      , 17-cv-11184-DPH-RSW, ED Mich (2018)."},{"key":"bibr23-0033354920904608","unstructured":"JEM v Kinkade\n                      , 2:16-cv-04273-SRB, DC WD Mo (2017)."},{"key":"bibr24-0033354920904608","unstructured":"Rini J. State changes hep C medication guidelines, avoids lawsuit. Delaware Online. June 7, 2016. https:\/\/www.delawareonline.com\/story\/news\/health\/2016\/06\/07\/state-changes-hep-c-medication-guidelines-avoids-lawsuit\/85554396. Accessed March 31, 2019."},{"key":"bibr25-0033354920904608","unstructured":"Sapatkin D. In major shift, Pa. to expand hepatitis C treatment for Medicaid patients. The Philadelphia Inquirer. May 16, 2017. https:\/\/www.philly.com\/philly\/health\/health-cents\/In-major-shift-Pa-will-expand-hepatitis-C-treatment-for-Medicaid-patients.html. Accessed March 31, 2019."},{"key":"bibr26-0033354920904608","unstructured":"Oregon Health Plan to end rationing of costly hepatitis C cure. The Seattle Times. December 19, 2018. https:\/\/www.seattletimes.com\/seattle-news\/northwest\/oregon-health-plan-to-end-ration-of-costly-hepatitis-c-cure. Accessed March 31, 2019."},{"key":"bibr27-0033354920904608","unstructured":"Miller GW. R.I. broadens Medicaid coverage for treatment of hepatitis C. Providence Journal. July 11, 2018. https:\/\/www.providencejournal.com\/news\/20180711\/ri-broadens-medicaid-coverage-for-treatment-of-hepatitis-c. Accessed March 31, 2019."},{"key":"bibr28-0033354920904608","unstructured":"Schencker L. As many as 7,000 Illinois Medicaid patients with hepatitis C gain new access to pricey\u2014but lifesaving\u2014drugs. Chicago Tribune. November 14, 2018. https:\/\/www.chicagotribune.com\/business\/ct-illinois-relaxes-restrictions-hepatitis-c-drugs-1115-story.html. Accessed March 31, 2019."},{"key":"bibr29-0033354920904608","unstructured":"Medicaid Act, 42 USC \u00a71396a(a)(10)(B) (2019)."},{"key":"bibr30-0033354920904608","unstructured":"Medicaid Act, 42 USC \u00a71396a(a)(8) (2019)."},{"key":"bibr31-0033354920904608","unstructured":"US Department of Health and Human Services, Centers for Medicare & Medicaid Services. Assuring Medicaid beneficiaries access to hepatitis C (HCV) drugs. November 5, 2015. https:\/\/www.medicaid.gov\/medicaid-chip-program-information\/by-topics\/prescription-drugs\/downloads\/rx-releases\/state-releases\/state-rel-172.pdf. Accessed March 31, 2019."},{"key":"bibr32-0033354920904608","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30404-1"},{"key":"bibr33-0033354920904608","unstructured":"American Association for the Study of Liver Diseases, Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing, and treating hepatitis C. Updated May 24, 2018. https:\/\/www.hcvguidelines.org\/sites\/default\/files\/full-guidance-pdf\/HCVGuidance_May_24_2018b.pdf. Accessed March 31, 2019."},{"key":"bibr34-0033354920904608","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.10.021"},{"key":"bibr35-0033354920904608","unstructured":"Postawko v Missouri Department of Corrections\n                      , 2:16-CV-4219-NKL-P, WD Mo (2017)."},{"key":"bibr36-0033354920904608","unstructured":"Ligons v Minnesota Department of Corrections\n                      , 15-CV-2210, D Minn (2019)."},{"key":"bibr37-0033354920904608","unstructured":"Americans with Disabilities Act, Pub L No 101-336, 42 USC \u00a712132 (2019)."},{"key":"bibr38-0033354920904608","doi-asserted-by":"crossref","unstructured":"Thompson v Davis\n                      , 295 F3d 890, 9th Cir (2002).","DOI":"10.1016\/S0309-1740(02)00126-2"},{"key":"bibr39-0033354920904608","unstructured":"Americans with Disabilities Act, Pub L No 101-336, 42 USC \u00a712102(1)(a) (2019)."},{"key":"bibr40-0033354920904608","unstructured":"US Department of Justice. Settlement agreement between the United States of America and Charlwell Operating, LLC under the Americans with Disabilities Act. May 10, 2018. https:\/\/www.ada.gov\/charlwell_sa.html. Accessed March 31, 2019."},{"key":"bibr41-0033354920904608","unstructured":"US Department of Justice. Settlement agreement between the United States of America and Selma Medical Associates, Inc. under the Americans with Disabilities Act. January 31, 2019. https:\/\/www.ada.gov\/selma_medical_sa.html. Accessed March 31, 2019."},{"key":"bibr42-0033354920904608","unstructured":"Community House, Inc. v City of Boise\n                      ,\n                      Idaho\n                      , 490 F3d 1041, 9th Cir (2007)."},{"key":"bibr43-0033354920904608","unstructured":"New Directions Treatment Services v City of Reading\n                      , 490 F3d 293, 3\u2009rd Cir (2007)."},{"key":"bibr44-0033354920904608","unstructured":"Americans with Disabilities Act, 42 USC \u00a712210(a) (2019)."},{"key":"bibr45-0033354920904608","unstructured":"Brown v Lucky Stores\n                      , 246 F3d 1182 (9th Cir 2001)."},{"key":"bibr46-0033354920904608","unstructured":"Americans with Disabilities Act, Pub L No 101-336, 42 USC \u00a712210(c) (2019)."},{"key":"bibr47-0033354920904608","unstructured":"American Association for the Study of Liver Diseases, Infectious Diseases Society of America. When and in whom to initiate HCV therapy. Updated September 21, 2017. https:\/\/www.hcvguidelines.org\/evaluate\/when-whom. Accessed March 31, 2019."}],"container-title":["Public Health Reports\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0033354920904608","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0033354920904608","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0033354920904608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:35:56Z","timestamp":1777628156000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0033354920904608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":47,"journal-issue":{"issue":"1_suppl","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1177\/0033354920904608"],"URL":"https:\/\/doi.org\/10.1177\/0033354920904608","relation":{},"ISSN":["0033-3549","1468-2877"],"issn-type":[{"value":"0033-3549","type":"print"},{"value":"1468-2877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}